Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Short bursts of intense exercise could help people get fit in time for summer

Short bursts of intense exercise – known as HIIT – could help you get back into shape by summer and stay that way, a UNSW Sydney exercise physiology researcher says.

17 Nov 2020

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.

17 Nov 2020

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.

16 Nov 2020

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three blood pressure medications and a lipid lowering medication taken alone or with aspirin.

16 Nov 2020

Additional monitoring after cardiac surgery may be needed for patients at risk of atrial fibrillation

Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

The fish oil-based medication known as omega-3 carboxylic acids or omega-3 CA did not decrease the risk of cardiac events compared to a placebo, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac events in patients one year after stent placement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

The use of the more potent antiplatelet medication ticagrelor was not superior to clopidogrel in the reduction of the rate of heart attack or severe complications among people undergoing an elective procedure to open a blocked artery, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Exposure to low-level blasts affects the brains of military and law-enforcement personnel

Military and law-enforcement personnel repeatedly exposed to low-level blasts have significant brain changes – including an increased level of brain injury and inflammation – compared with a control group, a new study has found.

16 Nov 2020

People taking placebo pills and statins experienced similar side effects, shows study

People taking dummy pills and statins experienced similar side effects in a new study.

15 Nov 2020

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

A single, daily pill combining blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking research presented today in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Baycrest scientists use individualized brain stimulation to treat aphasia in stroke survivors

Baycrest scientists are pioneering the use of individualized brain stimulation therapy to treat aphasia in recovering stroke patients.

12 Nov 2020

Blood biomarker may predict prognosis, recovery from stroke

Researchers at Mayo Clinic in Florida and collaborators have found that a biomarker in the blood may determine the extent of brain injury from different types of strokes and predict prognosis in these patients.

11 Nov 2020

Synthetic protein nanoparticle may treat aggressive brain cancer

A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

11 Nov 2020

Machine learning models predict critical events, mortality rate in COVID-19 patients

Mount Sinai researchers have developed machine learning models that predict the likelihood of critical events and mortality in COVID-19 patients within clinically relevant time windows.

11 Nov 2020

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

A new text by Kessler Foundation scientists focuses on the efficacy of cognitive rehabilitation across a variety of neurological conditions, with specific emphasis on treatment-related changes in the brain detectable via neuroimaging.

11 Nov 2020

Daily walnut consumption may reduce the risk of heart disease

Findings from a randomized controlled trial recently published in the Journal of the American College of Cardiology, indicate that people in their 60s and 70s who regularly consume walnuts may have reduced inflammation, a factor associated with a lower risk of heart disease, compared to those who do not eat walnuts.

10 Nov 2020

New report highlights the value in preventing and reducing stroke

A report released today has found thousands of lives and billions of dollars could be saved annually by preventing stroke and improving access to treatment and care.

10 Nov 2020

HBCUs offer pronounced benefits for African Americans

African Americans who attend Historically Black Colleges or Universities (HBCUs) may be at lower risk for health problems later in adulthood compared to African Americans who attend predominantly white institutions, a new study suggests.

10 Nov 2020

Stroke News and Research

Further Reading

Short bursts of intense exercise could help people get fit in time for summer

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Additional monitoring after cardiac surgery may be needed for patients at risk of atrial fibrillation

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Exposure to low-level blasts affects the brains of military and law-enforcement personnel

People taking placebo pills and statins experienced similar side effects, shows study

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

Baycrest scientists use individualized brain stimulation to treat aphasia in stroke survivors

Blood biomarker may predict prognosis, recovery from stroke

Synthetic protein nanoparticle may treat aggressive brain cancer

Machine learning models predict critical events, mortality rate in COVID-19 patients

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

Daily walnut consumption may reduce the risk of heart disease

New report highlights the value in preventing and reducing stroke

HBCUs offer pronounced benefits for African Americans

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News